Despite repeated warnings from CMS about the misclassification of EpiPens, Mylan still fails to pay the agency millions of dollars in rebates from EpiPen sales, reported CNBC.
Supply Chain
While Bentonville, Ark.-based Wal-Mart already enforces strict guidelines for shipping time frames and delivery compliance, its suppliers will be held to even higher expectations in 2017, according to Supply Chain Brain.
The Food and Drug Administration recently approved the FreeStyle Libre Pro system, a continuous glucose monitoring system developed by Abbott Park, Ill.-based Abbott.
The Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' cystic fibrosis drug Orkambi.
The Food and Drug Administration approved one of the first automated insulin delivery systems, created by Dublin, Ireland-based Medtronic. The device replicates the functions of the pancreas and is meant to help those with type 1 diabetes, according to U.S.…
Advertisement
The Conference Board's consumer-confidence index defied analyst expectations for September, reaching a figure that hasn't been seen since 2007, reported The Wall Street Journal.
More than 25 percent of cancer and hematology drug reviewers who left the Food and Drug Administration between 2001 and 2010 now work for or consult drug companies, according to a research letter published in The BMJ.
While the media, consumers and politicians have all weighed in on the issue of rising drug costs, one powerful voice is missing from the conversation — that of patient advocacy groups.
Amazon wants to build a massive delivery network in the U.S. capable of competing with FedEx and UPS in a move that could potentially alter the traditional seller-sender relationship, reports The Wall Street Journal.
Two-thirds of the world does not have access to basic radiology services like X-rays or ultrasounds, according to estimates from the World Health Organization. While disease outbreaks and national disasters are more highlighted issues, the radiology gap holds just as severe…